New advances in acute graft-versus-host disease prophylaxis
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3148.2003.00466.x/fullpdf
Reference62 articles.
1. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant;Alyea;Blood,1998
2. Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?;Ancin;Bone Marrow Transplantation,2001
3. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study;Andre-Schmutz;Lancet,2002
4. A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation;Antin;Bone Marrow Transplantation,2002
5. Interleukin-1 blockade does not prevent acute graft- versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation;Antin;Blood,2002
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Relationship between the blood concentrations of tacrolimus and voriconazole in hematopoietic stem cell transplant recipients;Int. Journal of Clinical Pharmacology and Therapeutics;2019-11-01
2. Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide;Biology of Blood and Marrow Transplantation;2018-02
3. Synthesis and Immunosuppressive Activity of New Mycophenolic Acid Derivatives;Medicinal Chemistry;2017-01-30
4. Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation;Journal of Oncology Pharmacy Practice;2015-03-22
5. Mycophenolate mofetil vs. methotrexate for the prevention of graft-versus-host-disease – Systematic review and meta-analysis;Leukemia Research;2014-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3